Follow the people · Insider
Jim Wassil
Jim Wassil files insider transactions with the SEC as a chief operating officer of Vaxcyte (PCVX). We hold 7 disclosed purchases and sales filed since 21 January 2021, 3 of them in the last 90 days.
- Files forPCVX
- Disclosed buys and sells7 in all, 3 in the last 90 days
- Last disclosure2 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 January 2021 — 2 September 2026Chief Operating Officer · Vaxcyte (PCVX)203 Form 4 lines · source: SEC Form 4
- Filed 10 June 2022 — 19 February 2024Other role · Icosavax (ICVX)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 1,273 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- exercised options over 2,250 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- ▼ sold on the open market 1,537 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- ▼ sold on the open market 713 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- ▼ sold on the open market 924 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- ▼ sold on the open market 303 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 1 September 2026 · filed 2 September 2026
- had shares withheld for tax on 1,432 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 2,250 shares of Vaxcyte (a derivative holding)SEC Form 42 September 2026Stock Option (right to buy) · traded 1 September 2026 · filed 2 September 2026
- exercised options over 2,250 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 861 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 1,389 shares of VaxcyteSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- exercised options over 2,250 shares of Vaxcyte (a derivative holding)SEC Form 45 August 2026Stock Option (right to buy) · traded 3 August 2026 · filed 5 August 2026
- exercised options over 516 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 1,788 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 456 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 6 shares of VaxcyteSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- exercised options over 516 shares of Vaxcyte (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 1,949 shares of VaxcyteSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 301 shares of VaxcyteSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 2,250 shares of VaxcyteSEC Form 41 May 2026Common Stock · traded 1 May 2026 · filed 1 May 2026
- ▼ sold on the open market 1,412 shares of VaxcyteSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 838 shares of VaxcyteSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- had shares withheld for tax on 975 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 2,427 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 4,968 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- had shares withheld for tax on 975 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 2,427 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- ▼ sold on the open market 4,968 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 10 March 2026 · filed 11 March 2026
- was granted 32,045 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 5,102 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,900 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- was granted 53,566 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 898 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,009 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 53,566 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 32,045 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 5,102 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,900 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- had shares withheld for tax on 898 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 1,009 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- had shares withheld for tax on 2,759 shares of VaxcyteSEC Form 410 September 2025Common Stock · traded 8 September 2025 · filed 10 September 2025
- had shares withheld for tax on 1,270 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 1,587 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 1,429 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- gave away 74,000 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 31 December 2024 · filed 3 March 2025
- was granted 72,536 shares of Vaxcyte (a derivative holding)SEC Form 43 March 2025Stock Option (right to buy) · traded 27 February 2025 · filed 3 March 2025
- exercised options over 2,638 shares of Vaxcyte (a derivative holding)SEC Form 43 March 2025Stock Option (right to buy) · traded 3 March 2025 · filed 3 March 2025
- exercised options over 5,362 shares of Vaxcyte (a derivative holding)SEC Form 43 March 2025Stock Option (right to buy) · traded 3 March 2025 · filed 3 March 2025
- was granted 21,726 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- was granted 5,649 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 28 February 2025 · filed 3 March 2025
- had shares withheld for tax on 2,869 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 28 February 2025 · filed 3 March 2025
- had shares withheld for tax on 1,270 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 28 February 2025 · filed 3 March 2025
- exercised options over 2,638 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- exercised options over 5,362 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- ▼ sold on the open market 5,915 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- ▼ sold on the open market 2,085 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- had shares withheld for tax on 3,015 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 44 February 2025Stock Option (right to buy) · traded 3 February 2025 · filed 4 February 2025
- exercised options over 8,000 shares of VaxcyteSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- ▼ sold on the open market 5,314 shares of VaxcyteSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- ▼ sold on the open market 2,666 shares of VaxcyteSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- ▼ sold on the open market 20 shares of VaxcyteSEC Form 44 February 2025Common Stock · traded 3 February 2025 · filed 4 February 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 43 January 2025Stock Option (right to buy) · traded 2 January 2025 · filed 3 January 2025
- exercised options over 8,000 shares of VaxcyteSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 1,356 shares of VaxcyteSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 5,483 shares of VaxcyteSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- ▼ sold on the open market 1,161 shares of VaxcyteSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 43 December 2024Stock Option (right to buy) · traded 2 December 2024 · filed 3 December 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 5,772 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 1,101 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 1,127 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- was granted 87,481 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- was granted 35,661 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Restricted Stock Units · traded 7 November 2024 · filed 8 November 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 44 November 2024Stock Option (right to buy) · traded 1 November 2024 · filed 4 November 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 4,955 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 2,174 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 631 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 240 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- exercised options over 1,585 shares of Vaxcyte (a derivative holding)SEC Form 429 October 2024Stock Option (right to buy) · traded 28 October 2024 · filed 29 October 2024
- exercised options over 3,464 shares of Vaxcyte (a derivative holding)SEC Form 429 October 2024Stock Option (right to buy) · traded 28 October 2024 · filed 29 October 2024
- exercised options over 1,585 shares of VaxcyteSEC Form 429 October 2024Common Stock · traded 28 October 2024 · filed 29 October 2024
- exercised options over 3,464 shares of VaxcyteSEC Form 429 October 2024Common Stock · traded 28 October 2024 · filed 29 October 2024
- exercised options over 8,000 shares of Vaxcyte (a derivative holding)SEC Form 43 October 2024Stock Option (right to buy) · traded 1 October 2024 · filed 3 October 2024
- exercised options over 8,000 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 2,312 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 3,349 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 2,339 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- exercised options over 10,000 shares of Vaxcyte (a derivative holding)SEC Form 418 September 2024Stock Option (right to buy) · traded 16 September 2024 · filed 18 September 2024
- exercised options over 10,000 shares of VaxcyteSEC Form 418 September 2024Common Stock · traded 16 September 2024 · filed 18 September 2024
- ▼ sold on the open market 1,784 shares of VaxcyteSEC Form 418 September 2024Common Stock · traded 16 September 2024 · filed 18 September 2024
- ▼ sold on the open market 7,994 shares of VaxcyteSEC Form 418 September 2024Common Stock · traded 16 September 2024 · filed 18 September 2024
- ▼ sold on the open market 222 shares of VaxcyteSEC Form 418 September 2024Common Stock · traded 16 September 2024 · filed 18 September 2024
- exercised options over 10,000 shares of Vaxcyte (a derivative holding)SEC Form 45 September 2024Stock Option (right to buy) · traded 3 September 2024 · filed 5 September 2024
- exercised options over 10,000 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 258 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 2,072 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 3,102 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 2,263 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 367 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 389 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 344 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 1,195 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 10 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- had shares withheld for tax on 5,545 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 2,977 shares of VaxcyteSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 23 shares of VaxcyteSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 1,226 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 1,663 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 111 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 1,634 shares of VaxcyteSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 906 shares of VaxcyteSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 460 shares of VaxcyteSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 1,753 shares of VaxcyteSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- ▼ sold on the open market 1,062 shares of VaxcyteSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- ▼ sold on the open market 185 shares of VaxcyteSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- exercised options over 3,551 shares of Vaxcyte (a derivative holding)SEC Form 419 April 2024Stock Option (right to buy) · traded 17 April 2024 · filed 19 April 2024
- exercised options over 3,551 shares of VaxcyteSEC Form 419 April 2024Common Stock · traded 17 April 2024 · filed 19 April 2024
- ▼ sold on the open market 2,323 shares of VaxcyteSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.